Sign inJoin waitlistJoin the waitlist

Ramez Eskander

Director, Gynecologic Oncology Fellowship · University of California (San Diego) Medical Center

Credentials: · · · ·

History

University of California (San Diego) Medical Center
Present

Gynecologic Oncology
2009–2012
Obstetrics and Gynecology
University of California (San Diego) Medical Center
2006–2009
University of California, San Diego School of Medicine
2002–2006

Research

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
New England Journal of Medicine · 2023 · First of 27 authors · 633 citations
Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta
Obstetrics and Gynecology · 2010 · 298 citations
Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta
Obstetrics and Gynecology · 2006 · 286 citations

Krishnansu Tewari
22 papers
Bradley Monk
16 papers
Michael McHale
16 papers
Razelle Kurzrock
16 papers
Cheryl Saenz
15 papers
Steven Plaxe
13 papers
Leslie Randall
12 papers · 4 as a fellow
Shu Kato
12 papers
David O'Malley
11 papers
Pratibha Binder
11 papers · 9 as a fellow
Brian Slomovitz
10 papers
Bang Hoang
9 papers

Clinical trials

Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
Principal investigator · Active not recruiting · Phase 3
National Cancer Institute (NCI)
2019–2026
Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2019–2027
Signatera Assessment in Early-Stage Endometrial Cancer
Site PI · Not yet recruiting
Natera, Inc.
2026–2034
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2031